Takeda Oncology
Liz Lewis serves as the Head of Global Oncology Patient Value, Policy, and Access at Takeda Oncology since June 2019, overseeing the company’s initiatives to enhance patient access and strengthen advocacy efforts. Additionally, Liz holds the position of Chief Counsel for Specialty Business Units and Research & Development, where legal strategies for various therapeutic areas are developed. Liz's career at Takeda Oncology spans from 2008 to 2018 in roles including Chief Counsel, Chief Compliance Officer, and Vice President. Liz earned a Doctor of Law (JD) from American University Washington College of Law and a Bachelor of Arts in Political Science and Government from Hamilton College.
Takeda Oncology
20 followers
In 2008, Takeda Pharmaceutical Company Limited acquired Millennium Pharmaceuticals and the resulting company became exclusively focused on oncology. In 2014, Takeda Oncology was created to become the global headquarters for Takeda’s oncology specialty business unit, in Cambridge, Massachusetts, on the former Millennium Pharmaceuticals site. AtTakeda Oncology they endeavor to deliver novel medicines to patients with cancer worldwide through our commitment to science, breakthrough innovation and passion for improving the lives of patients. This singular focus drives our aspirations to discover, develop and deliver breakthrough oncology therapies. By concentrating the power of leading scientific minds and the vast resources of a global pharmaceutical company, they are finding innovative ways to improve the treatment of cancer.They've built a portfolio of paradigm-changing therapies and a leading oncology pipeline. Though They've made great strides in our fight against cancer, they are determined to do more — to work harder and to reach higher. They continue to seek our aspirations with the same passion, agility and entrepreneurial spirit that has sustained our patient-centric culture and has made us the leaders in oncology that they are today.